You are using an outdated browser. We suggest you update your browser for a better experience. Click here for update.
Close this notification.
Skip to main content Skip to search

 

486 Results
Regimen
Cancer Type:
Hematologic, 
Leukemia - Chronic Myeloid (CML)
Show More Show more tags
, Show Less Show fewer tags
Intent: Palliative
Funding:
Exceptional Access Program
    asciminib - For the treatment of Philadelphia chromosome-positive chronic myeloid leukemia in chronic phase, based on criteria
Show More Show more tags
, Show Less Show fewer tags
Drugs Used:
asciminib
... Show more tags
, Collapse Show fewer tags
Quick Link(s):
Regimen Monograph
Jul 2025
Document
New
Aug 2025
Document
New
Aug 2025
Document
New
Aug 2025
Document
New
Aug 2025
Document
New
Aug 2025
Document
New
Aug 2025
Document
New
Aug 2025
Document
New
Aug 2025
Document
New
Aug 2025
Document
New
Aug 2025
Document
New
Aug 2025

Pages